Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
15,419
archived clinical trials in
Pulmonary

Reiterative Development and Evaluation Study of OSA Therapy System
A Multicenter, Prospective, Variable Duration, Reiterative Development and Evaluation Study of ApniCure's Therapy System(s) for the Treatment of Obstructive Sleep Apnea (OSA)
Status: Enrolling
Updated:  11/21/2013
Kentucky Research Group
mi
from
Louisville, KY
Reiterative Development and Evaluation Study of OSA Therapy System
A Multicenter, Prospective, Variable Duration, Reiterative Development and Evaluation Study of ApniCure's Therapy System(s) for the Treatment of Obstructive Sleep Apnea (OSA)
Status: Enrolling
Updated: 11/21/2013
Kentucky Research Group
mi
from
Louisville, KY
Click here to add this to my saved trials
Reiterative Development and Evaluation Study of OSA Therapy System
A Multicenter, Prospective, Variable Duration, Reiterative Development and Evaluation Study of ApniCure's Therapy System(s) for the Treatment of Obstructive Sleep Apnea (OSA)
Status: Enrolling
Updated:  11/21/2013
The Center for Sleep and Wake Disorders
mi
from
Chevy Chase, MD
Reiterative Development and Evaluation Study of OSA Therapy System
A Multicenter, Prospective, Variable Duration, Reiterative Development and Evaluation Study of ApniCure's Therapy System(s) for the Treatment of Obstructive Sleep Apnea (OSA)
Status: Enrolling
Updated: 11/21/2013
The Center for Sleep and Wake Disorders
mi
from
Chevy Chase, MD
Click here to add this to my saved trials
Reiterative Development and Evaluation Study of OSA Therapy System
A Multicenter, Prospective, Variable Duration, Reiterative Development and Evaluation Study of ApniCure's Therapy System(s) for the Treatment of Obstructive Sleep Apnea (OSA)
Status: Enrolling
Updated:  11/21/2013
SleepMed
mi
from
Columbia, SC
Reiterative Development and Evaluation Study of OSA Therapy System
A Multicenter, Prospective, Variable Duration, Reiterative Development and Evaluation Study of ApniCure's Therapy System(s) for the Treatment of Obstructive Sleep Apnea (OSA)
Status: Enrolling
Updated: 11/21/2013
SleepMed
mi
from
Columbia, SC
Click here to add this to my saved trials
Reiterative Development and Evaluation Study of OSA Therapy System
A Multicenter, Prospective, Variable Duration, Reiterative Development and Evaluation Study of ApniCure's Therapy System(s) for the Treatment of Obstructive Sleep Apnea (OSA)
Status: Enrolling
Updated:  11/21/2013
Sleep Medicine Associates of Texas (SMAT)
mi
from
Dallas, TX
Reiterative Development and Evaluation Study of OSA Therapy System
A Multicenter, Prospective, Variable Duration, Reiterative Development and Evaluation Study of ApniCure's Therapy System(s) for the Treatment of Obstructive Sleep Apnea (OSA)
Status: Enrolling
Updated: 11/21/2013
Sleep Medicine Associates of Texas (SMAT)
mi
from
Dallas, TX
Click here to add this to my saved trials
Vitamin D Supplementation and Acute Respiratory Infection in Older Long-Term Care Residents
Vitamin D Supplementation and Acute Respiratory Infection in Older Long-Term Care Residents
Status: Enrolling
Updated:  12/2/2013
University of Colorado Denver
mi
from
Aurora, CO
Vitamin D Supplementation and Acute Respiratory Infection in Older Long-Term Care Residents
Vitamin D Supplementation and Acute Respiratory Infection in Older Long-Term Care Residents
Status: Enrolling
Updated: 12/2/2013
University of Colorado Denver
mi
from
Aurora, CO
Click here to add this to my saved trials
Comparing Bubble and Ventilator Nasal CPAP in Preterm Infants
Comparing the Effects of Bubble Nasal CPAP Versus Ventilator Nasal CPAP in Preterm Infants
Status: Enrolling
Updated:  12/2/2013
Maimonides Medical Center
mi
from
Brooklyn, NY
Comparing Bubble and Ventilator Nasal CPAP in Preterm Infants
Comparing the Effects of Bubble Nasal CPAP Versus Ventilator Nasal CPAP in Preterm Infants
Status: Enrolling
Updated: 12/2/2013
Maimonides Medical Center
mi
from
Brooklyn, NY
Click here to add this to my saved trials
Rituximab for Pulmonary Sarcoidosis
Rituximab as a Novel Therapy in Refractory Sarcoidosis: A Prospective Open-
Status: Enrolling
Updated:  12/9/2013
University of Cincinnati
mi
from
Cincinnati, OH
Rituximab for Pulmonary Sarcoidosis
Rituximab as a Novel Therapy in Refractory Sarcoidosis: A Prospective Open-
Status: Enrolling
Updated: 12/9/2013
University of Cincinnati
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Efficacy of Ultrasound to Guide Management During a Rapid Response Event
Efficacy of Ultrasound to Guide Management During a Rapid Response Event
Status: Enrolling
Updated:  12/9/2013
Beth Israel Med Ctr
mi
from
New York, NY
Efficacy of Ultrasound to Guide Management During a Rapid Response Event
Efficacy of Ultrasound to Guide Management During a Rapid Response Event
Status: Enrolling
Updated: 12/9/2013
Beth Israel Med Ctr
mi
from
New York, NY
Click here to add this to my saved trials
A Drug Treatment for Cocaine Users Who Are Also on Methadone Maintenance Treatment
Atomoxetine Treatment for Opioid Maintained Cocaine Users
Status: Enrolling
Updated:  12/12/2013
Department of Veterans Affairs Hospital
mi
from
West Haven, CT
A Drug Treatment for Cocaine Users Who Are Also on Methadone Maintenance Treatment
Atomoxetine Treatment for Opioid Maintained Cocaine Users
Status: Enrolling
Updated: 12/12/2013
Department of Veterans Affairs Hospital
mi
from
West Haven, CT
Click here to add this to my saved trials
Dental Device for Treatment of Sleep Apnea
Health Outcomes of Treatment of Obstructive Sleep Apnea With Dental Devices
Status: Enrolling
Updated:  12/13/2013
Ohio State University
mi
from
Columbus, OH
Dental Device for Treatment of Sleep Apnea
Health Outcomes of Treatment of Obstructive Sleep Apnea With Dental Devices
Status: Enrolling
Updated: 12/13/2013
Ohio State University
mi
from
Columbus, OH
Click here to add this to my saved trials
Beneficial Effects of Quercetin in COPD - a Preliminary Clinical Trial
Phase I/II Study to Determine the Safety and Efficacy of Quercetin in COPD
Status: Enrolling
Updated:  12/16/2013
University of Michigan
mi
from
Ann Arbor, MI
Beneficial Effects of Quercetin in COPD - a Preliminary Clinical Trial
Phase I/II Study to Determine the Safety and Efficacy of Quercetin in COPD
Status: Enrolling
Updated: 12/16/2013
University of Michigan
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Problem-Solving Therapy for People With Major Depression and Chronic Obstructive Pulmonary Disease
Treating Older Patients With Major Depression and Severe COPD
Status: Enrolling
Updated:  12/19/2013
The Burke Rehabilitation Hospital
mi
from
White Plains, NY
Problem-Solving Therapy for People With Major Depression and Chronic Obstructive Pulmonary Disease
Treating Older Patients With Major Depression and Severe COPD
Status: Enrolling
Updated: 12/19/2013
The Burke Rehabilitation Hospital
mi
from
White Plains, NY
Click here to add this to my saved trials
Problem-Solving Therapy for People With Major Depression and Chronic Obstructive Pulmonary Disease
Treating Older Patients With Major Depression and Severe COPD
Status: Enrolling
Updated:  12/19/2013
Weill Medical College of Cornell University
mi
from
White Plains, NY
Problem-Solving Therapy for People With Major Depression and Chronic Obstructive Pulmonary Disease
Treating Older Patients With Major Depression and Severe COPD
Status: Enrolling
Updated: 12/19/2013
Weill Medical College of Cornell University
mi
from
White Plains, NY
Click here to add this to my saved trials
Hippocampal Neurogenesis in Human Subjects
Hippocampal Neurogenesis in Human Subjects (Pilot Study)
Status: Enrolling
Updated:  1/3/2014
UT Southwestern Medical Center at Dallas, Division on Addictions
mi
from
Dallas, TX
Hippocampal Neurogenesis in Human Subjects
Hippocampal Neurogenesis in Human Subjects (Pilot Study)
Status: Enrolling
Updated: 1/3/2014
UT Southwestern Medical Center at Dallas, Division on Addictions
mi
from
Dallas, TX
Click here to add this to my saved trials
Diaphragmatic Breathing Retraining in Heart Failure Patients: Health-Behavior Related Outcomes
Diaphragmatic Breathing Retraining in Heart Failure Patients: Health-Behavior Related Outcomes
Status: Enrolling
Updated:  1/7/2014
University of Nebraska Medical Center, Herat Failure Clinic
mi
from
Omaha, NE
Diaphragmatic Breathing Retraining in Heart Failure Patients: Health-Behavior Related Outcomes
Diaphragmatic Breathing Retraining in Heart Failure Patients: Health-Behavior Related Outcomes
Status: Enrolling
Updated: 1/7/2014
University of Nebraska Medical Center, Herat Failure Clinic
mi
from
Omaha, NE
Click here to add this to my saved trials
A 28-Day Parallel Group Study of TD-4208 in COPD
A Phase IIB, 28-Day, Randomized, Double-Blind Placebo-Controlled Parallel Group Study of Nebulized TD-4208 in Subjects With Chronic Obstructive Pulmonary Disease
Status: Enrolling
Updated:  1/16/2014
TBD
mi
from
TBD, CA
A 28-Day Parallel Group Study of TD-4208 in COPD
A Phase IIB, 28-Day, Randomized, Double-Blind Placebo-Controlled Parallel Group Study of Nebulized TD-4208 in Subjects With Chronic Obstructive Pulmonary Disease
Status: Enrolling
Updated: 1/16/2014
TBD
mi
from
TBD, CA
Click here to add this to my saved trials
Safety and Pharmacokinetic Study of N6022 in Subjects With Cystic Fibrosis Homozygous for the F508del-CFTR Mutation
A Phase 1b, Randomized, Double-Blind, Placebo-Controlled, Dose Escalation Study of N6022 to Evaluate Safety and Pharmacokinetics in Subjects With Cystic Fibrosis Homozygous for the F508del-CFTR Mutation (SNO1)
Status: Enrolling
Updated:  1/28/2014
University of Alabama at Birmingham
mi
from
Birmingham, AL
Safety and Pharmacokinetic Study of N6022 in Subjects With Cystic Fibrosis Homozygous for the F508del-CFTR Mutation
A Phase 1b, Randomized, Double-Blind, Placebo-Controlled, Dose Escalation Study of N6022 to Evaluate Safety and Pharmacokinetics in Subjects With Cystic Fibrosis Homozygous for the F508del-CFTR Mutation (SNO1)
Status: Enrolling
Updated: 1/28/2014
University of Alabama at Birmingham
mi
from
Birmingham, AL
Click here to add this to my saved trials
Safety and Pharmacokinetic Study of N6022 in Subjects With Cystic Fibrosis Homozygous for the F508del-CFTR Mutation
A Phase 1b, Randomized, Double-Blind, Placebo-Controlled, Dose Escalation Study of N6022 to Evaluate Safety and Pharmacokinetics in Subjects With Cystic Fibrosis Homozygous for the F508del-CFTR Mutation (SNO1)
Status: Enrolling
Updated:  1/28/2014
Providence Alaska Medical Center
mi
from
Anchorage, AK
Safety and Pharmacokinetic Study of N6022 in Subjects With Cystic Fibrosis Homozygous for the F508del-CFTR Mutation
A Phase 1b, Randomized, Double-Blind, Placebo-Controlled, Dose Escalation Study of N6022 to Evaluate Safety and Pharmacokinetics in Subjects With Cystic Fibrosis Homozygous for the F508del-CFTR Mutation (SNO1)
Status: Enrolling
Updated: 1/28/2014
Providence Alaska Medical Center
mi
from
Anchorage, AK
Click here to add this to my saved trials
Safety and Pharmacokinetic Study of N6022 in Subjects With Cystic Fibrosis Homozygous for the F508del-CFTR Mutation
A Phase 1b, Randomized, Double-Blind, Placebo-Controlled, Dose Escalation Study of N6022 to Evaluate Safety and Pharmacokinetics in Subjects With Cystic Fibrosis Homozygous for the F508del-CFTR Mutation (SNO1)
Status: Enrolling
Updated:  1/28/2014
Stanford University
mi
from
Stanford, CA
Safety and Pharmacokinetic Study of N6022 in Subjects With Cystic Fibrosis Homozygous for the F508del-CFTR Mutation
A Phase 1b, Randomized, Double-Blind, Placebo-Controlled, Dose Escalation Study of N6022 to Evaluate Safety and Pharmacokinetics in Subjects With Cystic Fibrosis Homozygous for the F508del-CFTR Mutation (SNO1)
Status: Enrolling
Updated: 1/28/2014
Stanford University
mi
from
Stanford, CA
Click here to add this to my saved trials
Safety and Pharmacokinetic Study of N6022 in Subjects With Cystic Fibrosis Homozygous for the F508del-CFTR Mutation
A Phase 1b, Randomized, Double-Blind, Placebo-Controlled, Dose Escalation Study of N6022 to Evaluate Safety and Pharmacokinetics in Subjects With Cystic Fibrosis Homozygous for the F508del-CFTR Mutation (SNO1)
Status: Enrolling
Updated:  1/28/2014
Children's Hospital Colorado
mi
from
Aurora, CO
Safety and Pharmacokinetic Study of N6022 in Subjects With Cystic Fibrosis Homozygous for the F508del-CFTR Mutation
A Phase 1b, Randomized, Double-Blind, Placebo-Controlled, Dose Escalation Study of N6022 to Evaluate Safety and Pharmacokinetics in Subjects With Cystic Fibrosis Homozygous for the F508del-CFTR Mutation (SNO1)
Status: Enrolling
Updated: 1/28/2014
Children's Hospital Colorado
mi
from
Aurora, CO
Click here to add this to my saved trials
Safety and Pharmacokinetic Study of N6022 in Subjects With Cystic Fibrosis Homozygous for the F508del-CFTR Mutation
A Phase 1b, Randomized, Double-Blind, Placebo-Controlled, Dose Escalation Study of N6022 to Evaluate Safety and Pharmacokinetics in Subjects With Cystic Fibrosis Homozygous for the F508del-CFTR Mutation (SNO1)
Status: Enrolling
Updated:  1/28/2014
National Jewish Health
mi
from
Denver, CO
Safety and Pharmacokinetic Study of N6022 in Subjects With Cystic Fibrosis Homozygous for the F508del-CFTR Mutation
A Phase 1b, Randomized, Double-Blind, Placebo-Controlled, Dose Escalation Study of N6022 to Evaluate Safety and Pharmacokinetics in Subjects With Cystic Fibrosis Homozygous for the F508del-CFTR Mutation (SNO1)
Status: Enrolling
Updated: 1/28/2014
National Jewish Health
mi
from
Denver, CO
Click here to add this to my saved trials
Safety and Pharmacokinetic Study of N6022 in Subjects With Cystic Fibrosis Homozygous for the F508del-CFTR Mutation
A Phase 1b, Randomized, Double-Blind, Placebo-Controlled, Dose Escalation Study of N6022 to Evaluate Safety and Pharmacokinetics in Subjects With Cystic Fibrosis Homozygous for the F508del-CFTR Mutation (SNO1)
Status: Enrolling
Updated:  1/28/2014
Northwestern University
mi
from
Chicago, IL
Safety and Pharmacokinetic Study of N6022 in Subjects With Cystic Fibrosis Homozygous for the F508del-CFTR Mutation
A Phase 1b, Randomized, Double-Blind, Placebo-Controlled, Dose Escalation Study of N6022 to Evaluate Safety and Pharmacokinetics in Subjects With Cystic Fibrosis Homozygous for the F508del-CFTR Mutation (SNO1)
Status: Enrolling
Updated: 1/28/2014
Northwestern University
mi
from
Chicago, IL
Click here to add this to my saved trials
Safety and Pharmacokinetic Study of N6022 in Subjects With Cystic Fibrosis Homozygous for the F508del-CFTR Mutation
A Phase 1b, Randomized, Double-Blind, Placebo-Controlled, Dose Escalation Study of N6022 to Evaluate Safety and Pharmacokinetics in Subjects With Cystic Fibrosis Homozygous for the F508del-CFTR Mutation (SNO1)
Status: Enrolling
Updated:  1/28/2014
University of Iowa Children's Hospital
mi
from
Iowa City, IA
Safety and Pharmacokinetic Study of N6022 in Subjects With Cystic Fibrosis Homozygous for the F508del-CFTR Mutation
A Phase 1b, Randomized, Double-Blind, Placebo-Controlled, Dose Escalation Study of N6022 to Evaluate Safety and Pharmacokinetics in Subjects With Cystic Fibrosis Homozygous for the F508del-CFTR Mutation (SNO1)
Status: Enrolling
Updated: 1/28/2014
University of Iowa Children's Hospital
mi
from
Iowa City, IA
Click here to add this to my saved trials
Safety and Pharmacokinetic Study of N6022 in Subjects With Cystic Fibrosis Homozygous for the F508del-CFTR Mutation
A Phase 1b, Randomized, Double-Blind, Placebo-Controlled, Dose Escalation Study of N6022 to Evaluate Safety and Pharmacokinetics in Subjects With Cystic Fibrosis Homozygous for the F508del-CFTR Mutation (SNO1)
Status: Enrolling
Updated:  1/28/2014
Johns Hopkins Hosp
mi
from
Baltimore, MD
Safety and Pharmacokinetic Study of N6022 in Subjects With Cystic Fibrosis Homozygous for the F508del-CFTR Mutation
A Phase 1b, Randomized, Double-Blind, Placebo-Controlled, Dose Escalation Study of N6022 to Evaluate Safety and Pharmacokinetics in Subjects With Cystic Fibrosis Homozygous for the F508del-CFTR Mutation (SNO1)
Status: Enrolling
Updated: 1/28/2014
Johns Hopkins Hosp
mi
from
Baltimore, MD
Click here to add this to my saved trials
Safety and Pharmacokinetic Study of N6022 in Subjects With Cystic Fibrosis Homozygous for the F508del-CFTR Mutation
A Phase 1b, Randomized, Double-Blind, Placebo-Controlled, Dose Escalation Study of N6022 to Evaluate Safety and Pharmacokinetics in Subjects With Cystic Fibrosis Homozygous for the F508del-CFTR Mutation (SNO1)
Status: Enrolling
Updated:  1/28/2014
Boston Children's Hospital
mi
from
Boston, MA
Safety and Pharmacokinetic Study of N6022 in Subjects With Cystic Fibrosis Homozygous for the F508del-CFTR Mutation
A Phase 1b, Randomized, Double-Blind, Placebo-Controlled, Dose Escalation Study of N6022 to Evaluate Safety and Pharmacokinetics in Subjects With Cystic Fibrosis Homozygous for the F508del-CFTR Mutation (SNO1)
Status: Enrolling
Updated: 1/28/2014
Boston Children's Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
Safety and Pharmacokinetic Study of N6022 in Subjects With Cystic Fibrosis Homozygous for the F508del-CFTR Mutation
A Phase 1b, Randomized, Double-Blind, Placebo-Controlled, Dose Escalation Study of N6022 to Evaluate Safety and Pharmacokinetics in Subjects With Cystic Fibrosis Homozygous for the F508del-CFTR Mutation (SNO1)
Status: Enrolling
Updated:  1/28/2014
Univ of Minnesota
mi
from
Minneapolis, MN
Safety and Pharmacokinetic Study of N6022 in Subjects With Cystic Fibrosis Homozygous for the F508del-CFTR Mutation
A Phase 1b, Randomized, Double-Blind, Placebo-Controlled, Dose Escalation Study of N6022 to Evaluate Safety and Pharmacokinetics in Subjects With Cystic Fibrosis Homozygous for the F508del-CFTR Mutation (SNO1)
Status: Enrolling
Updated: 1/28/2014
Univ of Minnesota
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Safety and Pharmacokinetic Study of N6022 in Subjects With Cystic Fibrosis Homozygous for the F508del-CFTR Mutation
A Phase 1b, Randomized, Double-Blind, Placebo-Controlled, Dose Escalation Study of N6022 to Evaluate Safety and Pharmacokinetics in Subjects With Cystic Fibrosis Homozygous for the F508del-CFTR Mutation (SNO1)
Status: Enrolling
Updated:  1/28/2014
Washington University
mi
from
St. Louis, MO
Safety and Pharmacokinetic Study of N6022 in Subjects With Cystic Fibrosis Homozygous for the F508del-CFTR Mutation
A Phase 1b, Randomized, Double-Blind, Placebo-Controlled, Dose Escalation Study of N6022 to Evaluate Safety and Pharmacokinetics in Subjects With Cystic Fibrosis Homozygous for the F508del-CFTR Mutation (SNO1)
Status: Enrolling
Updated: 1/28/2014
Washington University
mi
from
St. Louis, MO
Click here to add this to my saved trials
Safety and Pharmacokinetic Study of N6022 in Subjects With Cystic Fibrosis Homozygous for the F508del-CFTR Mutation
A Phase 1b, Randomized, Double-Blind, Placebo-Controlled, Dose Escalation Study of N6022 to Evaluate Safety and Pharmacokinetics in Subjects With Cystic Fibrosis Homozygous for the F508del-CFTR Mutation (SNO1)
Status: Enrolling
Updated:  1/28/2014
Univ of North Carolina
mi
from
Chapel Hill, NC
Safety and Pharmacokinetic Study of N6022 in Subjects With Cystic Fibrosis Homozygous for the F508del-CFTR Mutation
A Phase 1b, Randomized, Double-Blind, Placebo-Controlled, Dose Escalation Study of N6022 to Evaluate Safety and Pharmacokinetics in Subjects With Cystic Fibrosis Homozygous for the F508del-CFTR Mutation (SNO1)
Status: Enrolling
Updated: 1/28/2014
Univ of North Carolina
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
Safety and Pharmacokinetic Study of N6022 in Subjects With Cystic Fibrosis Homozygous for the F508del-CFTR Mutation
A Phase 1b, Randomized, Double-Blind, Placebo-Controlled, Dose Escalation Study of N6022 to Evaluate Safety and Pharmacokinetics in Subjects With Cystic Fibrosis Homozygous for the F508del-CFTR Mutation (SNO1)
Status: Enrolling
Updated:  1/28/2014
Cincinnati Children's Hospital Medical Center
mi
from
Cincinnati, OH
Safety and Pharmacokinetic Study of N6022 in Subjects With Cystic Fibrosis Homozygous for the F508del-CFTR Mutation
A Phase 1b, Randomized, Double-Blind, Placebo-Controlled, Dose Escalation Study of N6022 to Evaluate Safety and Pharmacokinetics in Subjects With Cystic Fibrosis Homozygous for the F508del-CFTR Mutation (SNO1)
Status: Enrolling
Updated: 1/28/2014
Cincinnati Children's Hospital Medical Center
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Safety and Pharmacokinetic Study of N6022 in Subjects With Cystic Fibrosis Homozygous for the F508del-CFTR Mutation
A Phase 1b, Randomized, Double-Blind, Placebo-Controlled, Dose Escalation Study of N6022 to Evaluate Safety and Pharmacokinetics in Subjects With Cystic Fibrosis Homozygous for the F508del-CFTR Mutation (SNO1)
Status: Enrolling
Updated:  1/28/2014
Rainbow Babies and Children's Hospital - Case Medical Center
mi
from
Cleveland, OH
Safety and Pharmacokinetic Study of N6022 in Subjects With Cystic Fibrosis Homozygous for the F508del-CFTR Mutation
A Phase 1b, Randomized, Double-Blind, Placebo-Controlled, Dose Escalation Study of N6022 to Evaluate Safety and Pharmacokinetics in Subjects With Cystic Fibrosis Homozygous for the F508del-CFTR Mutation (SNO1)
Status: Enrolling
Updated: 1/28/2014
Rainbow Babies and Children's Hospital - Case Medical Center
mi
from
Cleveland, OH
Click here to add this to my saved trials
Safety and Pharmacokinetic Study of N6022 in Subjects With Cystic Fibrosis Homozygous for the F508del-CFTR Mutation
A Phase 1b, Randomized, Double-Blind, Placebo-Controlled, Dose Escalation Study of N6022 to Evaluate Safety and Pharmacokinetics in Subjects With Cystic Fibrosis Homozygous for the F508del-CFTR Mutation (SNO1)
Status: Enrolling
Updated:  1/28/2014
Nationwide Children's Hospital
mi
from
Columbus, OH
Safety and Pharmacokinetic Study of N6022 in Subjects With Cystic Fibrosis Homozygous for the F508del-CFTR Mutation
A Phase 1b, Randomized, Double-Blind, Placebo-Controlled, Dose Escalation Study of N6022 to Evaluate Safety and Pharmacokinetics in Subjects With Cystic Fibrosis Homozygous for the F508del-CFTR Mutation (SNO1)
Status: Enrolling
Updated: 1/28/2014
Nationwide Children's Hospital
mi
from
Columbus, OH
Click here to add this to my saved trials
Safety and Pharmacokinetic Study of N6022 in Subjects With Cystic Fibrosis Homozygous for the F508del-CFTR Mutation
A Phase 1b, Randomized, Double-Blind, Placebo-Controlled, Dose Escalation Study of N6022 to Evaluate Safety and Pharmacokinetics in Subjects With Cystic Fibrosis Homozygous for the F508del-CFTR Mutation (SNO1)
Status: Enrolling
Updated:  1/28/2014
Children's Hospital of Philadelphia
mi
from
Philadelphia, PA
Safety and Pharmacokinetic Study of N6022 in Subjects With Cystic Fibrosis Homozygous for the F508del-CFTR Mutation
A Phase 1b, Randomized, Double-Blind, Placebo-Controlled, Dose Escalation Study of N6022 to Evaluate Safety and Pharmacokinetics in Subjects With Cystic Fibrosis Homozygous for the F508del-CFTR Mutation (SNO1)
Status: Enrolling
Updated: 1/28/2014
Children's Hospital of Philadelphia
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Safety and Pharmacokinetic Study of N6022 in Subjects With Cystic Fibrosis Homozygous for the F508del-CFTR Mutation
A Phase 1b, Randomized, Double-Blind, Placebo-Controlled, Dose Escalation Study of N6022 to Evaluate Safety and Pharmacokinetics in Subjects With Cystic Fibrosis Homozygous for the F508del-CFTR Mutation (SNO1)
Status: Enrolling
Updated:  1/28/2014
Children's Hospital of Pittsburgh of UPMC
mi
from
Pittsburgh, PA
Safety and Pharmacokinetic Study of N6022 in Subjects With Cystic Fibrosis Homozygous for the F508del-CFTR Mutation
A Phase 1b, Randomized, Double-Blind, Placebo-Controlled, Dose Escalation Study of N6022 to Evaluate Safety and Pharmacokinetics in Subjects With Cystic Fibrosis Homozygous for the F508del-CFTR Mutation (SNO1)
Status: Enrolling
Updated: 1/28/2014
Children's Hospital of Pittsburgh of UPMC
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Propofol vs Propofol + Benzo/Opiates in High Risk Group
Incidence of Sedation Related Complications With Propofol Alone Versus Propofol With Benzodiazepines and Opiates in a High Risk Group Undergoing Advanced Endoscopic Procedures: A Randomized Controlled Trial
Status: Enrolling
Updated:  1/31/2014
Washington University School of Medicine
mi
from
Saint Louis, MO
Propofol vs Propofol + Benzo/Opiates in High Risk Group
Incidence of Sedation Related Complications With Propofol Alone Versus Propofol With Benzodiazepines and Opiates in a High Risk Group Undergoing Advanced Endoscopic Procedures: A Randomized Controlled Trial
Status: Enrolling
Updated: 1/31/2014
Washington University School of Medicine
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Evaluating Instrumentation for Dental Devices Used in Treating Sleep Apnea
Phase One Study Evalauting Instrumentation for Dental Devices Used in Treating Sleep Apnea
Status: Enrolling
Updated:  2/4/2014
Dartmouth Hitchcock Medical Center
mi
from
Lebanon, NH
Evaluating Instrumentation for Dental Devices Used in Treating Sleep Apnea
Phase One Study Evalauting Instrumentation for Dental Devices Used in Treating Sleep Apnea
Status: Enrolling
Updated: 2/4/2014
Dartmouth Hitchcock Medical Center
mi
from
Lebanon, NH
Click here to add this to my saved trials
A Study to Investigate the Safety and Pharmacokinetics of a Single Dose of GSK2256294 in Healthy Young Males and Elderly Subjects
A Study to Evaluate the Effect of Age, Food and Gender on Tolerability and Pharmacokinetics of GSK2256294 Following a Single Oral Administration in Healthy Fed and Fasted Elderly Subjects. This Study Will Also Evaluate the Biliary Metabolites in Healthy Young Males Following a Single Dose of GSK2256294
Status: Enrolling
Updated:  2/13/2014
GSK Investigational Site
mi
from
Baltimore, MD
A Study to Investigate the Safety and Pharmacokinetics of a Single Dose of GSK2256294 in Healthy Young Males and Elderly Subjects
A Study to Evaluate the Effect of Age, Food and Gender on Tolerability and Pharmacokinetics of GSK2256294 Following a Single Oral Administration in Healthy Fed and Fasted Elderly Subjects. This Study Will Also Evaluate the Biliary Metabolites in Healthy Young Males Following a Single Dose of GSK2256294
Status: Enrolling
Updated: 2/13/2014
GSK Investigational Site
mi
from
Baltimore, MD
Click here to add this to my saved trials
Facilitating EndotracheaL Intubation by Laryngoscopy Technique and Apneic Oxygenation Within the Intensive Care Unit: The FELLOW Study
Facilitating EndotracheaL Intubation by Laryngoscopy Technique and Apneic Oxygenation Within the Intensive Care Unit
Status: Enrolling
Updated:  2/13/2014
Vanderbilt University Medical Center
mi
from
Nashville, TN
Facilitating EndotracheaL Intubation by Laryngoscopy Technique and Apneic Oxygenation Within the Intensive Care Unit: The FELLOW Study
Facilitating EndotracheaL Intubation by Laryngoscopy Technique and Apneic Oxygenation Within the Intensive Care Unit
Status: Enrolling
Updated: 2/13/2014
Vanderbilt University Medical Center
mi
from
Nashville, TN
Click here to add this to my saved trials
Patient Perception Questionnaire Validation
Validation of the Patient Perception Questionnaire
Status: Enrolling
Updated:  2/18/2014
Clayton Sleep Institute
mi
from
St Louis, MO
Patient Perception Questionnaire Validation
Validation of the Patient Perception Questionnaire
Status: Enrolling
Updated: 2/18/2014
Clayton Sleep Institute
mi
from
St Louis, MO
Click here to add this to my saved trials
Observational Study of Blood Pressure Measurements and Continuous Dialysis
Observational Study Evaluating the Hemodynamic Relationship Between Volume Removal and Pulse Pressure Variation During Renal Replacement Therapy
Status: Enrolling
Updated:  3/27/2014
University of Chicago Medical Center
mi
from
Chicago, IL
Observational Study of Blood Pressure Measurements and Continuous Dialysis
Observational Study Evaluating the Hemodynamic Relationship Between Volume Removal and Pulse Pressure Variation During Renal Replacement Therapy
Status: Enrolling
Updated: 3/27/2014
University of Chicago Medical Center
mi
from
Chicago, IL
Click here to add this to my saved trials
Mechanical Ventilation in the Emergency Department: A Prospective Cross-Sectional Study
Mechanical Ventilation in the Emergency Department: A Prospective Cross-Sectional Study
Status: Enrolling
Updated:  3/28/2014
Christiana Care Health System
mi
from
Newark, DE
Mechanical Ventilation in the Emergency Department: A Prospective Cross-Sectional Study
Mechanical Ventilation in the Emergency Department: A Prospective Cross-Sectional Study
Status: Enrolling
Updated: 3/28/2014
Christiana Care Health System
mi
from
Newark, DE
Click here to add this to my saved trials
Mechanical Ventilation in the Emergency Department: A Prospective Cross-Sectional Study
Mechanical Ventilation in the Emergency Department: A Prospective Cross-Sectional Study
Status: Enrolling
Updated:  3/28/2014
University of Iowa College of Medicine
mi
from
Iowa City, IA
Mechanical Ventilation in the Emergency Department: A Prospective Cross-Sectional Study
Mechanical Ventilation in the Emergency Department: A Prospective Cross-Sectional Study
Status: Enrolling
Updated: 3/28/2014
University of Iowa College of Medicine
mi
from
Iowa City, IA
Click here to add this to my saved trials
Mechanical Ventilation in the Emergency Department: A Prospective Cross-Sectional Study
Mechanical Ventilation in the Emergency Department: A Prospective Cross-Sectional Study
Status: Enrolling
Updated:  3/28/2014
Washington University School of Medicine
mi
from
Saint Louis, MO
Mechanical Ventilation in the Emergency Department: A Prospective Cross-Sectional Study
Mechanical Ventilation in the Emergency Department: A Prospective Cross-Sectional Study
Status: Enrolling
Updated: 3/28/2014
Washington University School of Medicine
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Mechanical Ventilation in the Emergency Department: A Prospective Cross-Sectional Study
Mechanical Ventilation in the Emergency Department: A Prospective Cross-Sectional Study
Status: Enrolling
Updated:  3/28/2014
University of Cincinnati College of Medicine
mi
from
Cincinnati, OH
Mechanical Ventilation in the Emergency Department: A Prospective Cross-Sectional Study
Mechanical Ventilation in the Emergency Department: A Prospective Cross-Sectional Study
Status: Enrolling
Updated: 3/28/2014
University of Cincinnati College of Medicine
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Human Behavioral Pharmacology Laboratory (HBPL) Study of Varenicline's Impact on Cocaine and Alcohol Craving
Status: Enrolling
Updated:  4/2/2014
University of Pennsylvania, Treatment Research Center
mi
from
Philadelphia, PA
Human Behavioral Pharmacology Laboratory (HBPL) Study of Varenicline's Impact on Cocaine and Alcohol Craving
Status: Enrolling
Updated: 4/2/2014
University of Pennsylvania, Treatment Research Center
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Study to Evaluate the Effect of KB001-A on Time-to-Need for Antibiotic Treatment
A Phase 2, Randomized, Double-blind, Placebo-controlled, Repeat-dose Study of KB001-A in Subjects With Cystic Fibrosis Infected With Pseudomonas Aeruginosa
Status: Enrolling
Updated:  4/2/2014
Clinical Research Facility
mi
from
Mobile, AL
Study to Evaluate the Effect of KB001-A on Time-to-Need for Antibiotic Treatment
A Phase 2, Randomized, Double-blind, Placebo-controlled, Repeat-dose Study of KB001-A in Subjects With Cystic Fibrosis Infected With Pseudomonas Aeruginosa
Status: Enrolling
Updated: 4/2/2014
Clinical Research Facility
mi
from
Mobile, AL
Click here to add this to my saved trials
Study to Evaluate the Effect of KB001-A on Time-to-Need for Antibiotic Treatment
A Phase 2, Randomized, Double-blind, Placebo-controlled, Repeat-dose Study of KB001-A in Subjects With Cystic Fibrosis Infected With Pseudomonas Aeruginosa
Status: Enrolling
Updated:  4/2/2014
Clinical Research Facility
mi
from
Phoenix, AZ
Study to Evaluate the Effect of KB001-A on Time-to-Need for Antibiotic Treatment
A Phase 2, Randomized, Double-blind, Placebo-controlled, Repeat-dose Study of KB001-A in Subjects With Cystic Fibrosis Infected With Pseudomonas Aeruginosa
Status: Enrolling
Updated: 4/2/2014
Clinical Research Facility
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Study to Evaluate the Effect of KB001-A on Time-to-Need for Antibiotic Treatment
A Phase 2, Randomized, Double-blind, Placebo-controlled, Repeat-dose Study of KB001-A in Subjects With Cystic Fibrosis Infected With Pseudomonas Aeruginosa
Status: Enrolling
Updated:  4/2/2014
Clinical Research Facility
mi
from
Tucson, AZ
Study to Evaluate the Effect of KB001-A on Time-to-Need for Antibiotic Treatment
A Phase 2, Randomized, Double-blind, Placebo-controlled, Repeat-dose Study of KB001-A in Subjects With Cystic Fibrosis Infected With Pseudomonas Aeruginosa
Status: Enrolling
Updated: 4/2/2014
Clinical Research Facility
mi
from
Tucson, AZ
Click here to add this to my saved trials
Study to Evaluate the Effect of KB001-A on Time-to-Need for Antibiotic Treatment
A Phase 2, Randomized, Double-blind, Placebo-controlled, Repeat-dose Study of KB001-A in Subjects With Cystic Fibrosis Infected With Pseudomonas Aeruginosa
Status: Enrolling
Updated:  4/2/2014
Clinical Research Facility
mi
from
Little Rock, AR
Study to Evaluate the Effect of KB001-A on Time-to-Need for Antibiotic Treatment
A Phase 2, Randomized, Double-blind, Placebo-controlled, Repeat-dose Study of KB001-A in Subjects With Cystic Fibrosis Infected With Pseudomonas Aeruginosa
Status: Enrolling
Updated: 4/2/2014
Clinical Research Facility
mi
from
Little Rock, AR
Click here to add this to my saved trials
Study to Evaluate the Effect of KB001-A on Time-to-Need for Antibiotic Treatment
A Phase 2, Randomized, Double-blind, Placebo-controlled, Repeat-dose Study of KB001-A in Subjects With Cystic Fibrosis Infected With Pseudomonas Aeruginosa
Status: Enrolling
Updated:  4/2/2014
Clinical Research Facility
mi
from
Long Beach, CA
Study to Evaluate the Effect of KB001-A on Time-to-Need for Antibiotic Treatment
A Phase 2, Randomized, Double-blind, Placebo-controlled, Repeat-dose Study of KB001-A in Subjects With Cystic Fibrosis Infected With Pseudomonas Aeruginosa
Status: Enrolling
Updated: 4/2/2014
Clinical Research Facility
mi
from
Long Beach, CA
Click here to add this to my saved trials
Study to Evaluate the Effect of KB001-A on Time-to-Need for Antibiotic Treatment
A Phase 2, Randomized, Double-blind, Placebo-controlled, Repeat-dose Study of KB001-A in Subjects With Cystic Fibrosis Infected With Pseudomonas Aeruginosa
Status: Enrolling
Updated:  4/2/2014
Clinical Research Facility
mi
from
Oakland, CA
Study to Evaluate the Effect of KB001-A on Time-to-Need for Antibiotic Treatment
A Phase 2, Randomized, Double-blind, Placebo-controlled, Repeat-dose Study of KB001-A in Subjects With Cystic Fibrosis Infected With Pseudomonas Aeruginosa
Status: Enrolling
Updated: 4/2/2014
Clinical Research Facility
mi
from
Oakland, CA
Click here to add this to my saved trials